Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+51.1K
-
Total reported value, excl. options
-
$2.55B
-
Value change
-
+$11.1M
-
Number of buys
-
115
-
Number of sells
-
-89
-
Price
-
$135.18
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2015
237 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2015.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.79M shares), VANGUARD GROUP INC (1.3M shares), ARIEL INVESTMENTS, LLC (1.14M shares), BlackRock Fund Advisors (683K shares), WELLS FARGO & COMPANY/MN (650K shares), BlackRock Institutional Trust Company, N.A. (599K shares), STATE STREET CORP (564K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (554K shares), NWQ INVESTMENT MANAGEMENT COMPANY, LLC (522K shares), and AMERICAN CENTURY COMPANIES INC (468K shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.